After having ramped up her exercise routine and trying multiple diets, including ketogenic, WeightWatchers and Whole30, she ...

Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of ...

Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

One the bigger drivers of Medicaid’s rising costs is the ballooning expense of covering weight loss drugs, a state Senate ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...

New research has found that nearly 137 million adults—or more than half of all U.S. adults—are eligible for semaglutide ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...